drugset
drugset / Trial / NCT05765617

Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients

NCT05765617 ↗

Phase 2 Completed 16 enrolled Universitas Sebelas Maret
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research is a study that compares the administration of calcitriol with the outcomes of COVID-19 patients

Timeline

Start
2021-07-01
Primary completion
2021-09-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 400 iu —

Indications

COVID-19